BioBoss
BioBoss is a podcast about leadership in the biopharma community. Hear directly from the founders and CEOs of today's most innovative companies. Listen in as Wyant Simboli Principal and branding veteran John Simboli poses the questions "What drives you? How do you create change? Why should people care?" to biopharma leaders and hear insights on this rapidly developing field.
- Update frequency
- every 26 days
- Average duration
- 34 minutes
- Episodes
- 89
- Years Active
- 2019 - 2025
Reenie McCarthy: CEO of Stealth BioTherapeutics
BioBoss host John Simboli speaks with Reenie McCarthy, CEO of Stealth BioTherapeutics, headquartered in Needham, MA.. Hear Reenie's thoughts about leadership in biopharma and how Stealth Biotherapeut…
Yochi Slonim: Founder and CEO of Anima Biotech
BioBoss host John Simboli speaks with Yochi Slonim, founder and CEO of Anima Biotech, headquartered in Boston with R&D in Tel Aviv.. Hear Yochi's thoughts about leadership in biopharma and how Anima …
Clive Richardson: CEO of Akari Therapeutics
BioBoss host John Simboli speaks with Clive Richardson, CEO of Akari Therapeutics, headquartered in London with offices in New York. Hear Clive's thoughts about leadership in biopharma and how Akari …
Welcome to Season 4 of BioBoss
BioBoss podcast host John Simboli reflects on the success of seasons 1, 2 and 3 and welcomes listeners to listen in on his conversations about leadership with biopharma founders and CEOs in BioBoss …
Stefan König: CEO of George Medicines
BioBoss host John Simboli speaks with Stefan König , CEO of George Medicines, headquartered in London. Hear Stefan’s thoughts about leadership in biopharma and how George Medicines is working to exte…
Derek Maetzold: CEO of Castle Biosciences
Derek Maetzold, CEO of Castle Biosciences shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Castle is leveraging its expertise in cancer genomics and the use of…
Bob Cobuzzi: CEO of Diffusion Pharmaceuticals
Bob Cobuzzi, Chief Executive Officer of Diffusion Pharmaceuticals,speaks with BioBoss John Simboli about leadership and how Diffusion Pharmaceuticals is working to develop novel therapies that enhanc…
Panna Sharma: CEO of Lantern Therapeutics
Panna Sharma, CEO of Lantern Pharma, headquartered in Dallas, Texas, shares his thoughts with BioBoss host John Simboli about leadership and how Lantern is working at the intersection of artificial i…
Nandan Padukone: CEO of IM Therapeutics
Nandan Padukone, CEO of IM Therapeutics, headquartered in Woburn, Massachusetts, shares his thoughts with BioBoss host John Simboli about leadership and how IM Therapeutics is targeting the root caus…
Matthew Gline: CEO of Roivant Sciences
"I think I've always found motivation from being able to take a highly technical topic and dig in. I'm never the person that knows most about the topic. But I strive to be like the person who knows t…
Koen De Witte: Managing Director of ReMYND
Koen De Witte, managing director of reMYND NV, headquartered in Leuven, Belgium, shares his thoughts with BioBoss host John Simboli about leadership and how reMYND is advancing treatments for Alzheim…
Lanny Sun: Co-founder of Silicon Therapeutics
Lanny Sun, co-founder of Silicon Therapeutics, recently acquired by Roivant Sciences. speaks with corporate branding veteran John Simboli about leadership in biopharma. Lanny also discusses how Silic…
Joan Perelló: Co-Founder and CEO of Sanifit
Joan Perelló, co-founder and CEO of Sanifit, shares his thoughts with BioBoss host John Simboli about leadership and how Sanifit is pursuing the development of treatments for progressive vascular cal…
Saiid Zarrabian: CEO of Kintara Therapeutics
Saiid Zarrabian, President and CEO of Kintara Therapeutics, shares his thoughts with BioBoss host John Simboli about leadership and how Kintara is pursuing the development of new cancer therapies for…
John Temperato: CEO of 9 Meters Biopharma
John Temperato, President and Chief Executive Officer of 9 Meters Biopharma, speaks with BioBoss host John Simboli about leadership in biopharma and how 9 Meters is advancing drug candidates for pati…
Shawn Singh: CEO of VistaGen Therapeutics
Shawn Singh, CEO of VistaGen, speaks with BioBoss host John Simboli about leadership and VistaGen's working to develop a new generation of medications for anxiety, depression and other central nervou…
Welcome to Season 3 of BioBoss
BioBoss podcast host John Simboli reflects on the success of seasons 1 and 2 and welcomes listeners to listen in on his conversations about leadership with biopharma founders and CEOs in BioBoss sea…
Bobby Gaspar: CEO of Orchard Therapeutics
Bobby Gaspar, founder and CEO of Orchard Therapeutics, speaks with BioBoss host John Simboli about leadership and how Orchard Therapeutics is pursuing the opportunity to change medicine and change t…
Itamar Kandel: CEO of HeartVista
Itamar Kandel, CEO of HeartVista, speaks with BioBoss host John Simboli about leadership and how HeartVista leverages machine learning to simplify diagnostic imaging and help physicians more accurate…
Mark Altmeyer: Founder and CEO of Arvelle Therapeutics
Mark Altmeyer, founder and CEO of Arvelle Therapeutics, speaks with BioBoss host John Simboli. Hear Mark’s thoughts about leadership and how Arvelle is working to bring new solutions to people living…